Evidence map›Paper›PMID 36092820›Full record

ArticleSTAR protocols2022

Differentiation of beta-like cells from human induced pluripotent stem cell-derived pancreatic progenitor organoids.

Sergio Pedraza-Arevalo, Ana-Maria Cujba, Mario Enrique Alvarez-Fallas, Rocio Sancho

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in STAR protocols, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Potential Use of Organoids in Regenerative Medicine.Tissue engineering and regenerative medicine · 2024
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

Sergio Pedraza-ArevaloCenter for Gene Therapy and Regenerative Medicine, Kings College London, London, SE1 9RT, UK.
Ana-Maria CujbaCenter for Gene Therapy and Regenerative Medicine, Kings College London, London, SE1 9RT, UK.
Mario Enrique Alvarez-FallasCenter for Gene Therapy and Regenerative Medicine, Kings College London, London, SE1 9RT, UK.
Rocio SanchoCenter for Gene Therapy and Regenerative Medicine, Kings College London, London, SE1 9RT, UK; Department of Internal Medicine III, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany. Electronic address: rocio.sancho@kcl.ac.uk.
King's College London · GB

Funding

Medical Research Council MR/S000011/1Medical Research Council MR/T015470/1Wellcome TrustWellcome Trust 108874/Z/15/ZWellcome Trust 207529/Z/17/Z
6 · The paper itself

Abstract

Human induced pluripotent stem cells (hiPSCs) and organoids are important for modeling human development and disease

Indexed as

Induced Pluripotent Stem CellsPluripotent Stem CellsCell DifferentiationHumansOrganoidsCell differentiationDevelopmental biologyMetabolismOrganoidsStem cells

Identifiers

PMID36092820
PMCPMC9449863
OpenAlexW4293704289

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.